Eli Lilly and Company is a pharmaceutical company with a focus on developing and selling a variety of prescription medicines. Jim Cramer discussed the stock's potential, emphasizing the need for new drug indications to boost its performance.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing